Free product worth Rs 499 on all myUpchar products
Wergomet 0.2 Mg Injection is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Post Delivery Bleeding.
Medical history of the patient along with age and gender determines the dosage of Wergomet 0.2 Mg Injection. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of Wergomet 0.2 Mg Injection are Headache, Abdominal Pain, Hypertension. Some other side effects of Wergomet 0.2 Mg Injection have been listed ahead. Such side effects of Wergomet 0.2 Mg Injection normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Wergomet 0.2 Mg Injection has a Unknown effect for pregnant women and Unknown effect on lactating mothers. Further, the section on Wergomet 0.2 Mg Injection related warnings talks about Wergomet 0.2 Mg Injection's effects on the liver, heart and kidney.
Wergomet 0.2 Mg Injection is contraindicated in people with pre-existing medical conditions like High Blood Pressure as it can result in adverse effects. Other contraindications of Wergomet 0.2 Mg Injection have been discussed in the sections ahead.
Drug reaction of Wergomet 0.2 Mg Injection with other medicines has been reported. See below for a complete list.
You should also be aware that Wergomet 0.2 Mg Injection is safe while driving, and is addiction.
Wergomet 0.2 Mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Female) |
|
Is the use of Wergomet 0.2 Mg Injection safe for pregnant women?
The effects of Wergomet on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Wergomet 0.2 Mg Injection safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Wergomet for breastfeeding women are not known.
What is the effect of Wergomet 0.2 Mg Injection on the Kidneys?
Wergomet rarely harms the kidneys.
What is the effect of Wergomet 0.2 Mg Injection on the Liver?
Wergomet can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Wergomet 0.2 Mg Injection on the Heart?
Wergomet may have severe effects on your heart, so do not take it without first consulting your doctor.
If you are suffering from any of the following diseases, you should not take Wergomet 0.2 Mg Injection unless your doctor advises you to do so -
Is this Wergomet 0.2 Mg Injection habit forming or addictive?
Wergomet 0.2 Mg Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Wergomet 0.2 Mg Injection will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Wergomet 0.2 Mg Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
Wergomet 0.2 Mg Injection is unable to treat or cure mental disorders.
Interaction between Food and Wergomet 0.2 Mg Injection
There is no information on the effects of taking Wergomet 0.2 Mg Injection with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Wergomet 0.2 Mg Injection
Due to lack of research, there is no information about the side effects of taking Wergomet 0.2 Mg Injection with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methergine® (methylergonovine maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 331-332
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 837-839
